Sabby Management’s Fibrocell Science Inc. FCSC Stock Holding History

Sabby Management’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-42,400	Closed	-$64K	–	147
2018 Q4	$64K	Buy	+42,400	New	+$84.8K	0.01%	93
2018 Q1	–	Sell	-225,718	Closed	-$733K	–	218
2017 Q4	$733K	Buy	+225,718	New	+$1.97M	0.07%	92
2014 Q1	–	Sell	-5,967	Closed	-$363K	–	291
2013 Q4	$363K	Sell	5,967 -10,766	-64%	-$627K	0.02%	162
2013 Q3	$1.1M	Buy	+16,733	New	+$1.35M	0.07%	116

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management's FCSC Position: Q1 2019 in Review

Sabby Management sold out of Fibrocell Science Inc. (FCSC) in Q1 2019, closing a stake of 42,400 shares — an estimated $64K sold.

Sabby Management first reported a position in FCSC in Q3 2013 and held it in 4 quarters. The position peaked at $1.1M in Q3 2013. 23 funds tracked by Wall St. Rank hold FCSC as of Q1 2019.

Sabby Management reported no remaining Fibrocell Science Inc. position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 42,400 Fibrocell Science Inc. shares in Q1 2019, an estimated $64K.
Sabby Management first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 4 quarters.
Sabby Management's Fibrocell Science Inc. position peaked at $1.1M in Q3 2013.
23 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.